Regulation, governance and ethics
S1R1C1
 

Our insights across all work include robust  interrogation of the regulation, governance and ethics of emerging genomic technologies and their implementation in healthcare.
S2R1C1
 

Regulation and governance of data, AI and medical devices

Recent developments  – at national and international levels  – in the regulation and governance of data, AI and medical devices are having significant impacts and potential impacts on the application of technology for health.

Find out more

 
S3R1C1
 

Genomics, medicine and population health to 2025

Designed for health system leaders, policy makers, and researchers, this peer-informed policy report examines the future of genomic medicine and public health. It addresses key challenges including: AI governance,  international data sharing, and regulatory fragmentation. It sets out a practical roadmap for equitable, sustainable population health genomics to 2050.

Find out more
S4R1C2
 

Recent advances are leading to great optimism about the use of synthetic data for health research and innovation, but privacy and regulatory issues remain.

Using synthetic data for health-related research and development
S5R1C1

An overview of the post-Brexit regulatory pathway for Advanced Therapy Medicinal Products in the UK and key challenges.

Regulating Advanced Therapy Medicinal Products in the UK after Brexit

Published 2024
S5R1C2

Ethical and legal considerations for personalised risk prediction and AI driven pathology to detect oesophageal cancer.

Human involvement in AI-driven digital pathology pathways

Published 2023
S5R1C3